Search

everythinglearnresearchcommunity

for

Search:↓

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

The woman has a type of scarring hair loss with red bumps around hair follicles.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Combining isotretinoin and dapsone effectively treated a challenging scalp condition.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Use lower concentrations of triamcinolone acetonide to reduce steroid-induced scalp atrophy.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

Topical tacrolimus can effectively treat erosive pustular dermatosis and related hair loss.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Alopecia areata patients often have eczema, thyroid issues, vitamin-D deficiency, and anemia.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

A person with thyroid problems had rare, swollen, bald spots on their scalp caused by a condition usually found on the shins.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.